Previous Article | Next Article ![]()
Journal of Virology, April 2000, p. 3166-3176, Vol. 74, No. 7
Fels Institute for Cancer Research and
Molecular Biology and Department of Biochemistry, Temple University
School of Medicine, Philadelphia, Pennsylvania 19140
Received 17 September 1999/Accepted 30 December 1999
The phosphorylation status of the pRB family of growth suppressor
proteins is regulated in a cell cycle entry-, progression-, and
exit-dependent manner in normal cells. We have shown previously that
p130, a member of this family, exhibits patterns of phosphorylated forms associated with various cell growth and differentiation stages.
However, human 293 cells, which are transformed cells that express the
adenoviral oncoproteins E1A and E1B, exhibit an abnormal pattern of
p130 phosphorylated forms. Here we report that, unlike pRB, the
phosphorylation status of both p130 and p107 is not modulated during
the cell cycle in 293 cells as it is in other cells. Conditional
overexpression of individual G1/S cyclins in 293 cells does
not alter the phosphorylation status of p130, suggesting that the
expression of E1A and/or E1B blocks hyperphosphorylation of p130. In
agreement with these observations, transient cotransfection of vectors
expressing E1A 12S, but not E1B, in combination with pocket proteins
into U-2 OS cells blocks hyperphosphorylation of both p130 and p107.
However, the phosphorylation status of pRB is not altered by
cotransfection of E1A 12S vectors. Moreover, MC3T3-E1 preosteoblasts
stably expressing E1A 12S also exhibit a block in hyperphosphorylation
of endogenous p130 and p107. Direct binding of E1A to p130 and p107 is
not required for the phosphorylation block since E1A 12S mutants
defective in binding to the pRB family also block hyperphosphorylation
of p130 and p107. Our data reported here identify a novel function of
E1A, which affects p130 and p107 but does not affect pRB. Since E1A does not bind the hyperphosphorylated forms of p130, this function of
E1A might prevent the existence of "free" hyperphosphorylated p130,
which could act as a CDK inhibitor.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
E1A Blocks Hyperphosphorylation of p130 and p107
without Affecting the Phosphorylation Status of the
Retinoblastoma Protein


*
Corresponding author. Mailing address: Fels Institute
for Cancer Research and Molecular Biology, Temple University School of
Medicine, AHP Bldg., Rm. 308, 3307 N. Broad St., Philadelphia, PA
19140. Phone: (215) 707-7416. Fax: (215) 707-5562/2102. E-mail: xavier{at}unix.temple.edu.
Present address: Institut de Recerca Oncologica, 08907 Barcelona, Spain.
Present address: Unitat de Biologia Cellular i Molecular, Institut
Municipal d'Investigació Medica, 08003 Barcelona, Spain.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|